We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $31.9M invested in Corvus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% more call options, than puts
Call options by funds: $79K | Put options by funds: $73K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 48 → 47 (-1)
3.15% less ownership
Funds ownership: 39.65% → 36.5% (-3.1%)
7% less capital invested
Capital invested by funds: $34.2M → $31.9M (-$2.36M)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
10
Reduced
14
Closed
8
Calls
$79K
Puts
$73K
Net Calls
+$6K
Net Calls Change
+$77K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$298K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$157K |
| 3 |
JP Morgan Chase
New York
|
+$109K |
| 4 |
Renaissance Technologies
New York
|
+$104K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$46.6K |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$2.11M |
| 2 |
Morgan Stanley
New York
|
-$509K |
| 3 |
SC
Samlyn Capital
New York
|
-$309K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$241K |
| 5 |
Two Sigma Investments
New York
|
-$163K |
